Moreover, the correlation between high RRM2 serum levels and higher tumor stage in liver cancer makes it a potential predictive marker of ferroptosis susceptibility and a targetable factor for cancer treatment (Yang et al., 2020; p. 2). The gene discussed is RRM2; the disease is neoplasm.